[HTML][HTML] The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases

AY Gasparyan, L Ayvazyan… - Annals of laboratory …, 2019 - synapse.koreamed.org
The platelet-to-lymphocyte ratio (PLR) has emerged as an informative marker revealing
shifts in platelet and lymphocyte counts due to acute inflammatory and prothrombotic states …

[HTML][HTML] Biomimetic platelet membrane-coated nanoparticles for targeted therapy

H Han, R Bartolo, J Li, MA Shahbazi… - European Journal of …, 2022 - Elsevier
The development of cell membrane-modified biomimetic nanoparticles has extensively
increased during the past years due to their exceptional biocompatibility, evasion from the …

Cardiovascular comorbidity in rheumatic diseases

MT Nurmohamed, M Heslinga, GD Kitas - Nature Reviews …, 2015 - nature.com
Patients with rheumatoid arthritis (RA) and other inflammatory joint diseases (IJDs) have an
increased risk of premature death compared with the general population, mainly because of …

Mean platelet volume: a link between thrombosis and inflammation?

A Yuri Gasparyan, L Ayvazyan… - Current …, 2011 - ingentaconnect.com
Platelet activation is a link in the pathophysiology of diseases prone to thrombosis and
inflammation. Numerous platelet markers, including mean platelet volume (MPV), have been …

New roles for mean platelet volume measurement in the clinical practice?

P Noris, F Melazzini, CL Balduini - Platelets, 2016 - Taylor & Francis
Several hundreds of studies recently investigated mean platelet volume (MPV) as measured
by electronic cell counters in a wide variety of acquired diseases, and most of them found …

Inflammation-induced thrombosis: mechanisms, disease associations and management

K Aksu, A Donmez, G Keser - Current pharmaceutical design, 2012 - ingentaconnect.com
Although inflammation-induced thrombosis is a well-known entity, its pathogenesis remains
complicated. There are complex interactions between inflammation and hemostasis …

Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study

A Ogdie, N Kay McGill, DB Shin… - European heart …, 2018 - academic.oup.com
Aims To determine the risk of venous thromboembolism (VTE) defined as the combined
endpoint of deep venous thrombosis (DVT) and pulmonary embolism (PE) among patients …

[HTML][HTML] Nonalcoholic fatty liver disease as a multi-systemic disease

H Fotbolcu, E Zorlu - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease.
NAFLD includes a wide spectrum of liver conditions ranging from simple steatosis to …

Artificial intelligence-based preventive, personalized and precision medicine for cardiovascular disease/stroke risk assessment in rheumatoid arthritis patients: a …

M Al-Maini, M Maindarkar, GD Kitas… - Rheumatology …, 2023 - Springer
The challenges associated with diagnosing and treating cardiovascular disease
(CVD)/Stroke in Rheumatoid arthritis (RA) arise from the delayed onset of symptoms …

Platelets: emerging facilitators of cellular crosstalk in rheumatoid arthritis

O Olumuyiwa-Akeredolu, MJ Page, P Soma… - Nature Reviews …, 2019 - nature.com
Rheumatoid arthritis (RA) is an autoimmune disease in which a variety of circulating pro-
inflammatory cells and dysregulated molecules are involved in disease aetiology and …